| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $675K | +0.0% |
| R&D Expense | $20.0M | +55.1% |
| SG&A Expense | $12.1M | +41.6% |
| Operating Income | -$32.1M | -54.6% |
| Net Income | -$36.7M | -20.2% |
| EPS (Basic) | -$0.56 | +56.3% |
| EPS (Diluted) | -$0.56 | +56.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $30.9M | +131.0% |
| Total Assets | $31.7M | +123.2% |
| Current Liabilities | $24.1M | +37.6% |
| Total Liabilities | $24.2M | +34.6% |
| Stockholders' Equity | $7.4M | +295.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.6M | -56.3% |
| Capital Expenditures | $72K | +500.0% |
| Investing Cash Flow | -$72K | -500.0% |
| Financing Cash Flow | $45.1M | +63.7% |
| Free Cash Flow | -$28.6M | -56.6% |